• Markets
    • icon
  • Companies
CAJ · ASX

Capitol Health Limited (ASX:CAJ)

AU$0.32

 0.0065 (2.027%)
ASX:Live
20/09/2024 12:10:13 PM
Near Resistance Near 52 Week High Hammer Bearish HALO Ords HALO Growth +4
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

CAJ Overview

CAJ Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Weak

Halo Model

MQV

Weak

GARP

Weak

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Neutral

Quality

Capital Efficiency

Weak

Balance Sheet

Strong

About CAJ

Website

Capitol Health Limited

Telephone

61.3.9348.3333

Address

Level 2 288 Victoria Parade East Melbourne, Victoria (VIC) 3002

Description

Capitol Health Ltd. provides diagnostic imaging and related services. It provides general x-ray, magnetic resonance imaging, ultrasound, mammography, doppler, orthopantomogram, echocardiography, computer tomography, computed tomography angiography, cone beam computed tomography, nuclear medicine, bone densitomety, and fluoroscopy services. The company was founded by Andrew Duncan Harrison on December 1, 2005 and is headquartered in Docklands, Australia.

CAJ Price Chart

Key Stats

Market Cap

AU$341.14M

PE

31.10

EV/EBITDA

8.2

Dividends Overview

DIV Yield

3.3%

Franking

100%

Ex Dividend Date (est.)

20-Sep-24

Market Data

52 weeks range

Low 0.19 - 0.32

Trade Value (12mth)

AU$134,174.00

1 week

-1.54%

1 month

8.47%

YTD

39.13%

1 year

52.38%

All time high

1.11

Key Fundamentals

EPS 3 yr Growth

-219.70%

EBITDA Margin

21.00%

Operating Cashflow

$36m

Free Cash Flow Return

14.40%

ROIC

-5.90%

Interest Coverage

6.30

Quick Ratio

0.40

Other Data

Shares on Issue (Fully Dilluted)

1064m

HALO Sector

Healthcare

Next Company Report Date

20-Aug-25

Ex Dividend Date (est.)

20-Sep-24

Next Dividend Pay Date (est.)

21-Oct-24

Reporting Currency

AUD

Short Sell (% of issue)

0.00

CAJ Announcements

Latest Announcements

Date Announcements

13 September 24

Release of Securities from Escrow

×

Release of Securities from Escrow

10 September 24

Notification of cessation of securities - CAJ

×

Notification of cessation of securities - CAJ

03 September 24

Change in substantial shareholding from AEF

×

Change in substantial shareholding from AEF

02 September 24

IDX: Proposed merger with Capitol Health Limited - Update

×

IDX: Proposed merger with Capitol Health Limited - Update

02 September 24

Proposed merger with IDX - Update

×

Proposed merger with IDX - Update

27 August 24

Dividend/Distribution - CAJ

×

Dividend/Distribution - CAJ

22 August 24

Appendix 4E and Annual Report

×

Appendix 4E and Annual Report

22 August 24

FY24 Results Release Announcement

×

FY24 Results Release Announcement

22 August 24

FY24 Results Presentation

×

FY24 Results Presentation

22 August 24

Final share buy-back notice

×

Final share buy-back notice

22 August 24

Appendix 4G

×

Appendix 4G

22 August 24

Corporate Governance Statement

×

Corporate Governance Statement

22 August 24

Notification of cessation of securities - CAJ

×

Notification of cessation of securities - CAJ

22 August 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

12 August 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

06 August 24

Change in substantial shareholding from AEF

×

Change in substantial shareholding from AEF

31 July 24

FY24 Financial Results Release Date

×

FY24 Financial Results Release Date

18 July 24

IDX: IDX & CAJ Sign Merger Implementation Deed

×

IDX: IDX & CAJ Sign Merger Implementation Deed

18 July 24

CAJ enters into Merger Implementation Deed with IDX

×

CAJ enters into Merger Implementation Deed with IDX

18 July 24

IDX: IDX/CAJ Merger Investor Presentation

×

IDX: IDX/CAJ Merger Investor Presentation

18 July 24

Variation of MD/CEO's Employment Agreement

×

Variation of MD/CEO's Employment Agreement

09 July 24

Notification regarding unquoted securities - CAJ

×

Notification regarding unquoted securities - CAJ

02 July 24

Change in substantial shareholding from AEF

×

Change in substantial shareholding from AEF

17 June 24

CAJ enters Process Deed following IDX's Indicative Proposal

×

CAJ enters Process Deed following IDX's Indicative Proposal

17 June 24

IDX: Integral Diagnostics & Capitol Health Proposed Merger

×

IDX: Integral Diagnostics & Capitol Health Proposed Merger

CAJ Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -11.1 -206.7 -26.1 Lock Lock Lock
     PE X Lock Lock Lock Lock 24.7 31.9 31.1 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 7.9 7.9 8.2 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.04 0.03 0.04 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.01 0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -14.2 -9.5 11.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock 2.8 3.5 2.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.01 0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 0.0 0.0 -10.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock 3.1 3.8 3.3 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 96 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.15 0.13 0.10 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 -0.04 -0.06 Lock Lock Lock
     Growth % Lock Lock Lock Lock 39.7 -237.3 -58.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,060 1,054 1,063 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,036 1,054 1,063 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 184 210 235 Lock Lock Lock
     Growth % Lock Lock Lock Lock 3.5 13.8 12.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 18 22 23 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 38 37 45 Lock Lock Lock
     Growth % Lock Lock Lock Lock -14.0 -3.1 20.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 20.8 17.7 19.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 79 82 81 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 41 40 49 Lock Lock Lock
     Growth % Lock Lock Lock Lock -14.4 -2.3 22.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 22.3 19.2 21.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 21 25 27 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 20 15 22 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.6 -23.7 45.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 10.9 7.3 9.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 16 -10 -12 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 5 1 3 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 11 -12 -15 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.0 -209.1 -26.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 5.8 -5.6 -6.3 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 32 37 36 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 13 17 19 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -14 -63 -19 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -26 31 -13 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 19 21 18 Lock Lock Lock
     Growth % Lock Lock Lock Lock -42.8 9.8 -9.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.1 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 13 19 24 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 266 324 319 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 71 130 133 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 68 122 120 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 112 188 209 Lock Lock Lock
Equity $m Lock Lock Lock Lock 153 135 111 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 224 265 244 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2.7 18.2 -7.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 4.0 -3.6 -4.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 7.0 -8.7 -13.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 8.4 6.0 8.4 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 4.7 -4.8 -5.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 14.0 15.3 14.4 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 14.0 7.5 6.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.6 3.0 2.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 44.3 90.5 108.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.6 0.5 0.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.6 0.5 0.4 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 66.6 70.0 77.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 95.0 74.1 51.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 35.4 38.8 42.2 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 1.7 4.9 3.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.7 0.6 0.7 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.7 0.6 0.7 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 8.7 -5.0 -4.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 6.0 -3.2 -3.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 31.2 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 4.0 -3.6 -4.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.7 2.4 2.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 7.0 -8.7 -13.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 3.8 190.1 164.2 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 0.3 -16.5 -22.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 10.3 9.4 8.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 10.3 9.4 8.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 5.4 14.3 16.8 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 4.9 -4.9 -8.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

20-Sep-24

DIV Yield

3.3%

Franking Level

100%

DPSg

-10.10%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CAJ Shortsell

Frequently Asked Questions

The current share price of Capitol Health Limited (CAJ:ASX) is AU$0.32.
The 52-week high share price for Capitol Health Limited (CAJ:ASX) is AU$0.32.
The 52-week low share price for Capitol Health Limited (CAJ:ASX)? is AU$0.19.
The current TTM dividend payout for Capitol Health Limited (CAJ:ASX) is 3.30.
The last dividend payment of Capitol Health Limited (CAJ:ASX) is AU$0.01.
Capitol Health Limited (CAJ:ASX) has a franking level of 100.0%.
Capitol Health Limited (CAJ:ASX) is classified in the Healthcare.
The current P/E ratio for Capitol Health Limited (CAJ:ASX) is 31.10.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.